Stanford University
Showing 27,241-27,260 of 34,446 Results
-
Andrew A. Shelton, MD, FACS, FACRS
Current Research and Scholarly InterestsMultimodality treatment of rectal cancer
Sphincter preserving procedures for rectal cancer
Laparoscopic colon and rectal surgery
Surgical education -
Elizabeth Shelton
Library Specialist 2, Education Library
BioProfessional interests include children's literature; special education. Interests/skills outside of work include gardening; landscape management; walking/day-hiking.
-
Dennis Shem
Clinical Assistant Professor, Surgery - Plastic & Reconstructive Surgery
BioDr. Shem is a Clinical Assistant Professor in the Section of Dental Medicine and Surgery at Stanford University. He trained in Dental Oncology at Memorial Sloan Kettering Cancer Center, focusing on oral complications of cancer therapy and non-surgical management of patients with osteoradionecrosis (ORN) and medication-related osteonecrosis of the jaw (MRONJ). He also trained in Oral and Maxillofacial Pathology at Columbia University and has expertise in diagnosing and managing oral mucosal diseases.
As a dental oncologist and oral pathologist, he evaluates patients before and after organ and stem-cell transplant, radiation therapy, chemotherapy, and bisphosphonate therapy. He has particular interest in oral manifestations of systemic disease, oral complications of systemic therapy, and oral dysplasia. -
Vered Karti Shemtov
Eva Chernov Lokey Senior Lecturer in Hebrew Language and Literature
BioVered Karti Shemtov teaches Hebrew and comparative literature in the Department of Comparative Literature at Stanford University, where she also serves as Faculty Director of the Center for Jewish Studies. Shemtov is the founder and editor-in-chief of the journal Dibur.
Her publications include Changing Rhythms: Towards a Theory of Prosody in Cultural Context (Bar-Ilan University Press, 2012) and several co-edited volumes, including Spoken Word, Written Word: Rethinking the Representation of Speech in Literature (2015), 1948: History and Responsibility (2013), and Jewish Conceptions and Practices of Space (2005). She is also the author of numerous articles, including “Limbotopia: The ‘New Present’ and the Literary Imagination” (Journal of Comparative Literature, 2018, with Elana Gomel); “A Sense of No Ending: Contemporary Literature and the Refusal to Write the Future” (Dibur Literary Journal, 2018, with Elana Gomel); and “Poetry and Dwelling: From Martin Heidegger to the Songbook of the Tent Revolution in Israel” (Prooftexts). Her scholarship also examines the works of Amos Oz, Yehuda Amichai, Michal Govrin, A. B. Yehoshua, and Zeruya Shalev. She is the author of the entry “Hebrew Poetry: 1781–2010” in the revised edition of The Princeton Encyclopedia of Poetry and Poetics.
Her current research project focuses on the poetics of rage and the literary, philosophical, and political forms through which rage is expressed and transformed in poetry and narrative. -
Andrew Shen
Ph.D. Student in Biomedical Data Science, admitted Autumn 2025
BioHi, my name is Andrew! I’m a current PhD student in Biomedical Data Science and an NSF Graduate Research Fellow. I am broadly interested in solving problems at the intersection of AI and science, but particularly in the areas of biology and medicine. Before my PhD, I worked at Harvard Medical School with Marinka Zitnik on developing machine learning methods for medicine and science.
Feel free to reach out to connect! -
Prof Christopher Shen MD
Adjunct Professor, Medicine - Surgery
Academic Staff - Hourly - CSL, SurgeryBioDr. Christopher Shen is an Adjunct Professor in the Stanford School of Medicine, the Director of Global Programs at the Stanford Mussallem Center for Biodesign, and a member of the Stanford Biodesign Leadership Council. Dr. Shen is also the Founding Executive Director of the Singapore Stanford Biodesign Program.
Dr. Shen has been a longstanding member of the Stanford community since 1991, completing degrees in Biological Sciences, Biomechanical Engineering, Business, and Medicine. He has been teaching graduate and undergraduate students since 2001.
A strong proponent of interdisciplinary and experiential education, Dr. Shen has dedicated his career to teaching medical, engineering, and business students at Stanford and abroad in foundational concepts underpinning design-thinking, clinical immersion, ideation, rapid prototyping, innovation, and entrepreneurship. In addition, Dr. Shen is responsible for establishing and/or managing collaborations between Stanford and Biodesign-like programs on every continent except Antarctica! He continues to annually mentor diverse groups of students to develop and implement innovative medical solutions to serve patients around the world.
Dr. Shen is the founding and current U.S. Executive Director of Singapore Stanford Biodesign since its inception in 2010. As the first Biodesign program in East Asia, its mission is to train the next generation of medical technology innovators throughout the Pacific Rim, focusing on the unique medical needs in the region. Supported by Singapore's national level research institute, the Agency for Science, Technology, and Research (ASTAR), and the National Research Foundation (NRF), the program has uniquely built bridges across Asia, spanning Singapore, China, Indonesia, Taiwan, Korea, Australia, and Malaysia. In total, the program has trained 60 Fellows and hundreds of students throughout the region.
Dr. Shen is also a Partner at Novo Holdings, the asset manager of the Novo Foundation, one of the largest philanthropic organizations in the world. With headquarters in Denmark, Novo Holdings is committed to investing in innovative companies that improve the health of people and planet. Dr. Shen started his career in medical innovation as a Senior Design Engineer at Guidant Neurovascular, where he was the principal inventor of one of the original stentriever devices for ischemic stroke. He has been issued twelve patents in the fields of interventional neuroradiology and interventional cardiology.
Dr. Shen was a Stanford Asia/Pacific Scholar and a Paul & Daisy Soros Fellow.
